Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls

By Microbix Admin | November 2, 2022

November 2, 2022 | by Microbix Admin | Media Featured Poster Publication | 0 comments